tiprankstipranks
Yumanity Therapeutics Announces Effectiveness of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta, Inc.
PremiumPress ReleasesYumanity Therapeutics Announces Effectiveness of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta, Inc.
1y ago
Yumanity Therapeutics Announces Filing of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta
PremiumPress Releases
Yumanity Therapeutics Announces Filing of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta
2y ago
Yumanity Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
PremiumPress Releases
Yumanity Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
2y ago
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
PremiumPress ReleasesYumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100